<SEC-DOCUMENT>0001193125-19-033881.txt : 20190429
<SEC-HEADER>0001193125-19-033881.hdr.sgml : 20190429
<ACCEPTANCE-DATETIME>20190211153432
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001193125-19-033881
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20190211

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CATALYST BIOSCIENCES, INC.
		CENTRAL INDEX KEY:			0001124105
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				562020050
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		611 GATEWAY BLVD., SUITE 710
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		650-871-0761

	MAIL ADDRESS:	
		STREET 1:		611 GATEWAY BLVD., SUITE 710
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TARGACEPT INC
		DATE OF NAME CHANGE:	20000919
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML><HEAD>
<TITLE>CORRESP</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g703279catalystbiosciences.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>VIA EDGAR </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">February&nbsp;11, 2019 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">United States Securities and Exchange
Commission </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Division of Corporation Finance </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">100 F Street,
N.E. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Washington, D.C. 20549 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attn: Mr.&nbsp;Jeffrey Gabor
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Re:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Catalyst Biosciences, Inc. </B></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>&nbsp;&nbsp;</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Registration Statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT></B></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>&nbsp;&nbsp;</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>File No.&nbsp;333- 228970</B></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>&nbsp;&nbsp;</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Request for Acceleration of Effectiveness </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Mr. Gabor: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to Rule 461 under the Securities Act
of 1933, as amended, Catalyst Biosciences, Inc., a Delaware corporation (the &#147;<I>Company</I>&#148;), hereby requests that the Securities and Exchange Commission (the &#147;<I>Commission</I>&#148;) take appropriate action to cause the
above-referenced Registration Statement to become effective at 4:00 PM Eastern Time on February&nbsp;14, 2019, or as soon thereafter as practicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Please contact Stephen B. Thau of Morrison&nbsp;&amp; Foerster LLP, counsel to the Company, at (650) <FONT STYLE="white-space:nowrap">813-5640</FONT> should
you have any questions or require additional information regarding this request and to notify us that the Registration Statement has been declared effective pursuant to this acceleration request. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Very truly yours,</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>CATALYST BIOSCIENCES, INC.</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Fletcher Payne</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Fletcher Payne</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Chief Financial Officer</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="96%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">cc:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Stephen B. Thau, Morrison&nbsp;&amp; Foerster LLP</TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g703279catalystbiosciences.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g703279catalystbiosciences.jpg
M_]C_X  02D9)1@ ! 0$#P /   #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  O ),# 2(  A$! Q$!_\0
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M 'E.M?$+P=X6^%_A:'1]6FOM;\*SV]]&?L%RING&5N\L8P,R1RS]3U85Z?\
M&2\AU#P_X,NK>19K>;Q-I$D<BGAE:X0@CZ@UZ/=1PW$+P3A'CF4HT;]'!&",
M=^*X.W^$X@\"^&/#DNL231:!J%M>0W+PC<T5O-OBB(W=D"INS_#G':@#&_:
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MVNL,<.0S-G&(E_.I;_X>ZSXA\*:YH7B+QF-6BU".-(Y4T^*W-OM?<3A6^;.
M.>F* -5OA5HLGP]L?"#?:%LK-(O)NH9"EQ'-&P=9U<<B3>-^[N2<YR:Y?Q%'
MX]^&.@:AX@'BJW\6:5I4#W5SI^IZ>D-Q)!&NY]D\14>9M!QN0@GKC.:[SQ?X
M97Q=I*VD>JWVCW,<BW%O>Z;/Y<D;KT..5=>2"K J<].E<A>?"O7_ !);KIOB
MGQU<:OH;D"XT^VT^&T-XHY,<LBY8H?X@FW(R.AQ0 _X]W"7GP5UR>,DQRQ6\
MBY&#@S1D5Z57.>/O"MMXT\)WGA^>[^P1W@1!(@!8;75\ 'K]VM76;>:ZL7A@
MO%L'D^4S%-Q [XY&#[U,FXQ;2NRHI-V;L>=?$;Q7_:%R=,M7S;0M^]93P[CM
M]!_/Z5XQXJO]0UK4(O#F@PRW5_-_K5@Z@?W<]AW)/ 'XU[G_ ,*GMY@4&LMN
M;^*.)=P]QDGG\*Z'P?X)T+P/');:9&HNYOGGGF</<3'U8]<>PP*^3PN6XBOC
M'C,<MME>_I\E^>I[M?&4J6'6'PK]7_7<\6_X9AGL?!L]R]V;GQ(J^:EO%CR<
M#K&#C);WX&<#WKPCQ#ILFH67E?,)8&9UC;UX##V)P/R%?H-7SA^T%\-_[)OC
MXDT^+%E=/B[11Q'*?X_HW\_K7D\59;.<5CZ-[QTDO+O_ )_>?0\+9HL/4^JS
MTN[Q?GV?KT^X\I_9H\='P7\2K:VG?98:L!93 G #D_NV/T;CZ.:^Y:_.+Q)I
MC6LPOK?*?-ERO!5NS?Y[U]U?"#QPOQ"^'VDZNS!KLQ^3=@=IDX?CMG[P]F%7
MPGCE4IRPK>VJ_7\?S._C/!*3IYC36DO=EZK;\-/DCLZ***_03\P/D#X?R? R
MS^&=G=^*;:Q_MR..9KN58)S<;O,?!#(/O8Q@@UZ/X=_M??\  @ZW-)/J3->-
M))-())&4V,QCWL.&;9MR><G-4/AG\5#X)^'NF^&KKPCK%_J5JLD)2)[/R96:
M1B!N:<'!W#DK^%;'A;P#K/AE?@_97D$8FTRZU":[2&0&.V$L$Y2)2<;@GF*@
MP/X?2@ ^'GPU\.?%CP_=>*O%NFIKFKZE?WH6:Z=F-K#'<21110\_NPJ(.5P2
M<DG-<M)=27GACP];>+3J&N^#-#U[5M+U60)).TBP2O'9O<JGS.B@88D$$A2V
M:ZG1_%M_\$8IO"=]X<O=722^NIM%NM/GM]MS'-,\JQR>9(AC=3(5)P00,@]J
MT=#F\1_"#P7:W=_H*ZT;Z^O=3UL:?=QK)9R7$S2J(UDVK*J[]I^8'@$ YH K
MZ'?_  [\-^%/&7B/X;3Z<MU9:7-//9Z;.1"K)&SHSV^=JMD8W;0<9&:;H?P
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;7((]#Z8Z=**_5(XBE)*2EN?F$L)7BVG!G__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
